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SUMMARY  1 
 2 
 Low-grade systemic inflammation associated to obesity leads to cardiovascular 3 
complications, caused partly by infiltration of adipose and vascular tissue by effector T cells. 4 
The signals leading to T cell differentiation and tissue infiltration during obesity are poorly 5 
understood. 6 
 We tested whether saturated fatty acid-induced metabolic stress affects 7 
differentiation and trafficking patterns of CD4+ T cells. Memory CD4+ T cells primed in high-8 
fat diet-fed donors preferentially migrated to non-lymphoid, inflammatory sites, independent 9 
of the metabolic status of the hosts. This was due to biased CD4+ T cell differentiation into 10 
CD44hi-CCR7lo-CD62Llo-CXCR3+-LFA1+ effector memory-like T cells upon priming in high-fat 11 
diet-fed animals. Similar phenotype was observed in obese subjects in a cohort of free-living 12 
people.  13 
 This developmental bias was independent of any crosstalk between CD4+ T cells and 14 
dendritic cells and was mediated via direct exposure of CD4+ T cells to palmitate, leading to 15 
increased activation of a PI3K p110/Akt-dependent pathway upon priming.  16 
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INTRODUCTION 1 
 2 
 Obesity is a major and ever growing burden on public health worldwide. Individuals 3 
with obesity are at increased risk of several health conditions including type 2 diabetes, 4 
dyslipidaemia, liver steatosis, hypertension, cardiovascular disease, osteoarthritis, as well as 5 
various forms of cancer (Faulds and Dahlman-Wright, 2012; Mauro and Marelli-Berg, 2012; 6 
Norata et al., 2015). A strong link between obesity and the establishment of chronic systemic 7 
inflammation has recently emerged (Bjorndal et al., 2011), and is often related to increased 8 
expression of adipokines (i.e. leptin, chemerin, resistin), myokines and pro-inflammatory 9 
mediators [i.e. tumour necrosis factor (TNF)-α, interleukin (IL)-1 and IL-6], and decreased 10 
expression of the anti-inflammatory cytokine, adiponectin (Norata et al., 2015). In obesity, 11 
activated immune cells [including T cells, macrophages and dendritic cells (DC)] infiltrate 12 
adipose tissue, promoting in turn the production of pro-inflammatory cytokines such as TNF-13 
α, IL-6, resistin and monocyte chemotactic protein-1 (MCP-1/CCL2), (Mathis and Shoelson, 14 
2011; Norata et al., 2015). This process is thought to underlay the activation of both the 15 
innate and adaptive arms of the immune system, which results in the chronic inflammatory 16 
response observed in obese subjects (Larbi et al., 2008; Shaw et al., 2010). While T cells, B 17 
cells, macrophages, neutrophils and mast cells are increased in number in the visceral 18 
adipose tissue (AT) of obese individuals, specific subsets of T cells [helper T cell type (Th2), 19 
regulatory T cells and invariant natural killer T (iNKT)] cells as well as eosinophils are 20 
reduced (Cildir et al., 2013). Obesity-related inflammation, caused by excessive and 21 
inappropriate activation of the immune system, is pivotal to disease progression and the 22 
development of complications such as atherosclerosis and type II diabetes (Norata et al., 23 
2015). T lymphocytes play a major role in the development of these inflammatory processes 24 
both via direct cytotoxic activities and secretion of cytokines that influence the severity and 25 
outcome of the inflammatory reaction (Hamann et al., 2000). Based on the observation that 26 
T cells in the adipose tissue display specific T cell receptor (TCR) rearrangements it has 27 
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been proposed that obesity might be associated with an autoimmune response (Gerriets and 1 
Rathmell, 2012). 2 
 The mechanisms of enhanced T cell activation and tissue infiltration during obesity, 3 
however, remain elusive. 4 
 Altered antigen presentation by DC has been proposed to underlie the activation of 5 
adaptive immunity observed in dyslipidaemia. Although AT-derived DC in obesity display an 6 
immature phenotype with lower expression of activation markers such as CD40, CD80 and 7 
CD86 (Chen et al., 2014), they promote the differentiation of pro-inflammatory interferon 8 
(IFN)CD4+ T cells (Chen et al., 2014). 9 
 A very recent report has implicated dietary long- and medium-chain fatty acids (FA) 10 
in T cell differentiation towards Th1 and Th17 subsets in autoimmune responses of the 11 
central nervous system (Haghikia et al., 2015), however whether FA can directly affect T cell 12 
activation and differentiation towards specific cell subsets during metabolic overload remains 13 
to be established. 14 
 In this study, we investigated the phenotypic, functional and migratory features of 15 
memory CD4+ T cells in experimental models of saturated FA-induced metabolic stress, as 16 
well as in human CD4+ T cells obtained from individuals in a large cohort of free-living 17 
people [Progressione della Lesione Intimale Carotidea (PLIC) study: n=2,606]. Mechanistic 18 
studies show that direct exposure of CD4+ T cells to saturated FA, i.e. palmitate, which is 19 
enriched in high-fat diet (HFD), induces CD4+ T cells to acquire a specific CD44hi-CCR7lo-20 
CD62Llo-CXCR3+-LFA1+ pro-inflammatory functional phenotype via enhanced engagement 21 
of a PI3K p110/Akt-dependent pathway upon priming, but independent of the modality of 22 
antigen presentation by DC. 23 
24 
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RESULTS 1 
 2 
Priming following HFD induces differentiation of a CD4+ T cell population that readily 3 
migrates to inflamed, non-lymphoid tissues independent of the metabolic status of 4 
the host. 5 
 6 
 Given that lymphocyte infiltration of non-lymphoid tissues is a prominent feature of 7 
chronic inflammation, we first assessed whether HFD-induced metabolic stress directly 8 
promotes the generation of T cell populations with specific migratory features. To this aim, 9 
memory CD4+ T cells were generated in Rag2-deficient TCR transgenic Marilyn female 10 
mice, which harbour monoclonal CD4+ T cells specific for the male antigen H-Y (Lantz et al., 11 
2000), by i.p. injection of male splenocytes (Robertson et al., 2007). CD4+ T cells were then 12 
isolated from the lymph nodes of donors fed 8-week chow (CD) or high-fat (HFD) diet, and 13 
adoptively transferred in HFD- or CD-fed (i.e. fed chow or high-fat diet for 8 weeks, 14 
respectively) C57BL/6 male recipients  that had been i.p. injected with zymosan and IFN 48 15 
hours earlier to induce localized inflammation (Fig S1A-C), (Fu et al., 2014). In vivo-primed 16 
CD4+ T cells isolated from HFD donors exited from the blood circulation of CD recipients 17 
with a kinetic 24 hours faster than their CD counterpart (Fig 1A). CD4+ T cells that were 18 
primed in HFD donors also trafficked preferentially to the non-lymphoid, inflamed sites 19 
(peritoneal cavity) of both HFD and CD recipients (Fig 1B). In contrast, primed CD4+ T cells 20 
from CD donors preferentially localized to the mesenteric lymph nodes of both CD and HFD 21 
recipients (Fig 1C). No difference in CD4+ T cell localization to the spleen was observed 22 
when comparing equal numbers of adoptively transferred CD and HFD donors (Fig 1D). 23 
These results indicate that memory T cell populations induced in CD or HFD-fed animals are 24 
characterized by different trafficking patterns. 25 
 To establish the pathophysiological relevance of these differential trafficking patterns, 26 
we performed HY-mismatched skin grafts whereby male skin was implanted on the upper 27 
right back of CD or HFD-fed Marilyn female recipients. We found that rejection of HY-28 
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mismatched skin was significantly accelerated in HFD as compared to CD female recipients 1 
(Fig 1E), (Molinero et al., 2016). Activation of CD4+ T cells and their localization to the graft 2 
are known to be instrumental to rejection in this system (Chen et al., 2003). Indeed, we 3 
observed that HY-mismatched skin graft rejection was completely abrogated in Rag2KO 4 
mice (that are deficient for mature T and B cells) independent of the diet they received (Fig 5 
S1D). Reconstitution of HFD Rag2KO mice with CD4+ T cells isolated from Marilyn mice 6 
resulted in a rapid rejection of the transplanted male-derived skin (Fig S1D), showing the 7 
crucial role these cells play in such system. These findings support the conclusion that 8 
biased differentiation of CD4+ T cells towards a pro-inflammatory effector memory phenotype 9 
takes place during HFD-induced metabolic stress. 10 
 11 
HFD-induced metabolic stress promotes the differentiation of primed CD4+ T cells to a 12 
CXCR3+-LFA1+ effector memory-like phenotype in mice. 13 
 14 
 Based on the distinct homing preferences of memory T cells generated in HFD- or 15 
CD-fed animals and the stronger immune response elicited in HFD animals, we asked 16 
whether a biased differentiation of activated CD4+ T cells towards a pro-inflammatory 17 
phenotype – and associated homing receptors - takes place upon priming following HFD-18 
induced metabolic stress. 19 
 Using the same immunization procedure as that used for the experiments presented 20 
in Fig 1A-D, we found that HFD-fed hosts displayed an increase in the size of the CD44hi-21 
CCR7lo-CD62Llo-CXCR3+-LFA1+ effector memory-like CD4+ T cell population and no 22 
difference in the CD44hi-CCR7hi-CD62Lhi central memory CD4+ T cells as compared to CD4+ 23 
T cells primed in CD-fed mice (Fig 2A-D and S2A-D). In contrast, the size of naïve T cells 24 
was reduced in HFD (Fig 2A-B and S2A-B). These data suggest a preferential CD4+ T cell 25 
differentiation towards an effector memory phenotype under HFD regimen in concomitance 26 
with a reciprocal reduction of the naïve cell population without affecting the size of the 27 
central memory pool. No difference was observed in the expression of the activation markers 28 
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CD25 and CD44 (Fig 2E-F and S2E-F) by memory CD4+ T cells activated in CD or HFD 1 
hosts, indicative of similar priming efficiency in either metabolic background. In agreement 2 
with the observed phenotypes, a significantly larger fraction of in vivo-primed CD4+ T cells 3 
isolated from the lymph nodes of HFD mice migrated in response to the pro-inflammatory 4 
chemokine CXCL10 (a CXCR3 ligand) in ex vivo chemotaxis assays, whilst most in vivo-5 
primed CD4+ T cells isolated from the lymph nodes of CD mice migrated to the homeostatic 6 
lymphoid tissue chemokines CCL19 and CCL21 (ligands of CCR7), (Fig 2G). To investigate 7 
the cellular sources of CXCL10 in vivo, mice received an i.p. injection of IFN 48 hours later 8 
intracellular staining of CXCL10 in a number of immune cell populations retrieved from the 9 
peritoneal cavity was performed. We chose this system because of its relevance to the 10 
peritoneal recruitment system shown in Fig 1A-D. Data indicate that resident (peritoneal) and 11 
to a less extent infiltrating (monocyte-derived) macrophages are main sources of CXCL10 in 12 
this model (Fig S2G-H). Furthermore, we observed an increase in the IFN+ and IL4+ 13 
populations upon priming following HFD (Fig 2H-I). 14 
 Our findings are in line with previous work showing that increased expression of 15 
CXCR3 in inflammatory conditions, such as obesity and atherosclerosis, drives accumulation 16 
of inflammatory T cells in fat sites. Indeed, CXCR3- or CXCL10-deficient mice are protected 17 
from obesity- and atherosclerosis-induced inflammation in association with reduced 18 
accumulation of effector T cells and macrophages in AT and atherosclerotic plaques (Gupta 19 
et al., 1997; Rocha et al., 2014; Veillard et al., 2005). 20 
 21 
Obesity is associated with increased numbers of circulating CXCR3+ effector memory 22 
T cells in humans. 23 
 24 
 A cohort of 1,172 subjects was selected by probability sampling from a large survey 25 
of free-living people (PLIC study: n=2,606; average age 66 years). The selected cohort was 26 
representative of the entire PLIC cohort in terms of age, gender and clinical parameters 27 
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according to the Kolmogorov-Smirnov test; individuals were stratified in three groups (i.e. 1 
lean, overweight and obese), based on body mass index (BMI), and a number of 2 
biochemical and cellular markers of their peripheral blood were analysed (Table S1). In 3 
particular, this analysis revealed increased total lymphocyte counts in the blood of 4 
overweight and obese as compared to lean individuals (Table S1, Fig 3A). From this cohort, 5 
a detailed immunophenotype was performed in a group of n=187 subjects. Again, these 6 
individuals were selected by probability sampling and were representative of the entire 7 
cohort according to the Kolmogorov-Smirnov test. Specific subsets of circulating CD4+ T 8 
cells were assessed by 10-parameter/8-color polychromatic flow-cytometry with CD3, CD4, 9 
CD45RO, CD45RA, CCR7, CCR5, CXCR3, and HLA-DR as markers. The main CD4+ T cell 10 
subsets present in the blood were identified by flow cytometry based on a well-defined 11 
gating strategy (Fig S3A-B). The percentage of total T-helper lymphocytes was equal in the 12 
three groups (Fig 3B); however, we found a strong association of the obese condition with 13 
reduced naïve T cells and increased effector memory T cells (Fig 3C-D). 14 
 To gain further insights in to the relationship in humans between obesity and the 15 
effector memory phenotype of CD4+ T cells we focused on the few very obese patients in 16 
our cohort (BMI>35kg/m2, n=5) and observed that percentage of effector memory T cells 17 
was raised to 18.2% [11.2-21.3] as compared to 13.4% [8.8-18.25] of the entire obese 18 
population (Fig 3D-E) and to 10.2% [8.4-12.5] of the lean population (see Fig 3D). To 19 
address the potential link of this phenotype with obesity-related chronic inflammation, we 20 
also analyzed the blood levels of C reactive protein (CRP) in the lean, overweight and obese 21 
subjects. As expected CRP levels rose progressively with increasing BMI (Fig S4A), 22 
corroborating the correlation between obesity and inflammation. However, no significant 23 
correlation was observed between CRP levels and effector memory T cells (Fig S4B). 24 
Furthermore, no correlation between fasting glucose levels and effector memory T cells was 25 
observed (p=0.117). Also, effector memory T cells were not significantly increased in type 2 26 
diabetes subjects (n=13) as compared to the rest of the subjects in the cohort (p= 0.069). 27 
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 The body mass fat distribution of each individual was also analysed by dual-energy 1 
X-ray absorptiometry (Fig S4C) and the resulting android/gynoid ratio was correlated with 2 
the percent of various T cell subsets. The android/gynoid ratio correlated negatively with the 3 
naïve T cell subset (Fig 3F) and positively with the CXCR3+ effector memory T cell subset 4 
(Fig 3G-H). No significant correlation between the android/gynoid ratio and HLADR+ or 5 
CCR5+ effector memory T cell subsets was observed instead (Fig S4D-E). 6 
 7 
Antigen presentation by DC from metabolically stressed donors does not affect T cell 8 
differentiation to a pro-inflammatory effector memory-like phenotype. 9 
 10 
 Prompted by previous suggestions that altered antigen presentation by DC might 11 
affect T cell activation during metabolic stress (Chen et al., 2014; Shamshiev et al., 2007), 12 
we assessed the effect of splenic DC purified from HFD or CD animals on T cell activation 13 
and differentiation. We found that in vitro co-cultures of DC isolated from the spleen of CD-14 
fed C57BL/6 male mice with CD4+ T cells obtained from the lymph nodes of CD-fed Marilyn 15 
mice induced a strong proliferative response of Marilyn CD4+ T cells, which was reduced 16 
when CD4+ T cells were isolated from donors fed HFD (Fig 4A and S5A). In contrast, DC 17 
purified from the spleen of C57BL/6 male mice fed HFD were significantly less effective in 18 
promoting CD4+ T cell proliferation compared to their ‘CD-fed’ counterpart, irrespective of the 19 
T cell metabolic status [i.e. CD or HFD CD4+ T cell donors (Fig 4A and S5A), in line with 20 
previous reports (Shamshiev et al., 2007)]. These data suggest that the metabolic status of 21 
DC plays a role in determining their ability to promote CD4+ T cell proliferation. However, it 22 
did not affect the differentiation of CD4+ T cells to central versus effector memory phenotype. 23 
Indeed, HFD CD4+ T cells showed higher percent of CD44hi-CCR7lo-CD62lo-CXCR3+ cells as 24 
compared to CD CD4+ T cells (consistent with Fig 2A-C) independent of whether they were 25 
co-cultured with DC from HFD- or CD-fed donors (Fig 4B). Similar results were obtained in 26 
vivo when CD4+ T cells isolated from female Marilyn mice were co-injected with DC from 27 
HFD or CD C57BL/6 male donors in C57BL/6 female recipients (i.e. reduced CD4+ T cell 28 
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proliferation in the presence of DC from HFD-fed mice and no effect on central memory 1 
versus effector memory differentiation; Fig S5B-C). 2 
 In line with previous reports (Shamshiev et al., 2007), DC isolated from HFD-fed mice 3 
showed impaired activation as indicated by reduced expression of the activation markers 4 
CD80 and CD86 as compared to lean DC (Fig 4C). 5 
 6 
CD4+ T cell exposure to saturated FA causes enhanced activation of a PI3K p110/Akt-7 
dependent pathway upon priming. 8 
 9 
 Having ruled out a possible role for altered antigen presentation by DC in biasing 10 
CD4+ T cell differentiation to the CXCR3+ effector memory phenotype observed during HFD-11 
induced metabolic stress, we sought to establish whether CD4+ T cell intrinsic alterations 12 
were responsible for this event by interrogating pathways controlling nutrient responses in T 13 
cells. PI3K/Akt and mammalian target of rapamycin complexes (mTORC1 and mTORC2) 14 
are known to be rapidly activated upon T cell priming and control transcriptional and 15 
metabolic programs that sustain cell activation (Finlay et al., 2012; Macintyre et al., 2011). 16 
We found a substantial increase in the levels of Akt activation (phosphorylation at serine 17 
473, a target of mTORC2) in in vivo-primed CD4+ T cells isolated from the lymph nodes of 18 
HFD- as compared to CD-fed mice (Fig 5A, compare lanes 6-8 versus 1-2). Similar results 19 
were obtained with CD4+ T cells isolated from the peripheral blood of obese versus lean 20 
individuals selected from the PLIC cohort (Fig 5B). In contrast, threonine 308 on Akt and the 21 
mTORC1 target S6 did not undergo any significant modulation when comparing in vivo-22 
primed CD4+ T cells isolated from the lymph nodes of HFD or CD mice (Fig 5A and S6A). In 23 
line with recent literature (Finlay et al., 2012; Macintyre et al., 2011) our data suggest that 24 
CD4+ T cell priming following HFD regimen triggers a PI3K/Akt pathway via mTORC2 but 25 
does not result in downstream mTORC1 activation. 26 
 A recent report has implicated direct signaling induced by dietary FA in T cell 27 
differentiation in the gut, with middle- and long-chain FA supporting Th1 and Th17 cell 28 
11 
 
differentiation and short-chain FA promoting Treg cell development (Haghikia et al., 2015). In 1 
line with previous evidence, using lipidomic analysis we found that HFD alters the fatty acid 2 
and phospholipid profile of T cells (Fig S6B), resulting in increased membrane fluidity (Fig 3 
5C). This might underlay a reduced threshold for TCR clustering and activation in HFD 4 
(Swamy et al., 2016). Indeed, ImageStream analysis enabled us to observe that in vitro 5 
activation of T cells isolated from HFD as compared to CD mice results in increased 6 
aggregation of Cholera enterotoxin (CTx) B staining (Fig 5D and S6C), indicative of 7 
enhanced formation of lipid rafts, a key signaling event downstream of TCR engagement 8 
(Viola et al., 1999). The saturated FA palmitate has been shown to directly promote the 9 
activation of the inflammasome via NLRP3 and ASC (Wen et al., 2011) and of the Toll-like 10 
receptor (TLR) 4/MyD88 pathway (Eguchi et al., 2012). We therefore reasoned that the 11 
observed effector memory phenotype and enhanced activation of the PI3K/Akt pathway 12 
during CD4+ T cell ‘HFD priming’ could be due to a direct effect of the saturated FA 13 
palmitate, whose levels increase during HFD. Mirroring the results shown in Fig 2A-D, we 14 
found that palmitate enriched diet (PED)-fed animals displayed an increase in the size of the 15 
CD44hi- CCR7lo-CD62Llo-CXCR3+-LFA1+ effector memory-like CD4+ T cell population and no 16 
difference in the CD44hi-CCR7hi-CD62Lhi central memory CD4+ T cells as compared to CD4+ 17 
T cells primed in the corresponding palmitate control diet (PCD) fed-mice (Fig 5E-H). In 18 
contrast, the size of the naïve T cell subset was reduced upon PED (Fig 5E-H). Further, 19 
CD4+ T cells were cultured over-night with IL-7 in the presence or absence of either palmitic 20 
or linoleic acid at a concentration which mirrors plasma levels in obese individuals (200M), 21 
followed by activation with anti-CD3 and anti-CD28 for the indicated time points. As shown in 22 
Fig 5I, CD4+ T cell activation in the presence of palmitic acid for 2 hours showed a trend of 23 
enhanced Akt activation compared to linoleic acid or untreated control without any 24 
modulation of S6. In similar experimental settings, only CD4+ T cell activation in the 25 
presence of palmitic but not stearic acid for 48 hours led to reduced levels of CCR7 and 26 
CD62L mRNA (Fig 5J). In line with previous reports (Eguchi et al., 2012; Wen et al., 2011) 27 
these data suggest the existence of specific sensing mechanisms for palmitate. 28 
12 
 
 To further link the activation of the PI3K/Akt pathway to the observed specific CD4+ T 1 
cell differentiation during ‘HFD priming’, we activated CD4+ T cells via CD3/CD28 antibody 2 
ligation in the presence or absence of the Akt activator SC79. As expected, such treatment 3 
led to marked Akt phosphorylation (Fig S6D). Importantly, enhanced Akt activation led to 4 
reduced levels of CCR7 and CD62L mRNA as well as CCR7 protein (Fig 5K-L), indicating 5 
that increased Akt activation during CD4+ T cell priming directly promotes the pathway 6 
leading to the differentiation of effector memory-like T cells. 7 
 8 
The PI3K/Akt pathway is key for the differentiation of CXCR3+ effector memory T cells. 9 
 10 
 We addressed the question as to whether enhanced PI3K/Akt activation as we 11 
observed during ‘HFD priming’ in CD4+ T cells was instrumental to the biased T cell 12 
differentiation to the observed CXCR3+ effector memory phenotype. The p110 subunit of 13 
PI3K is crucial for correct TCR signaling and T cell activation (Okkenhaug et al., 2002). 14 
Furthermore, p110 engagement during T cell priming is instrumental for Akt activation and 15 
differentiation towards an effector memory phenotype, at least in CD8+ T cells (Finlay et al., 16 
2012; Macintyre et al., 2011). We therefore took genetic and pharmacologic approaches to 17 
selectively target p110 and Akt activities in vivo. First, allogeneic CD4+ T cells were primed 18 
in vivo in HFD-fed p110D910A (expressing kinase-dead p110) or wild-type (WT) mice. 19 
Genetic inhibition of p110 activity completely reversed CD4+ effector memory differentiation 20 
in HFD-fed animals (Fig 6A-D). This was accompanied by a reduction of both Akt activation 21 
on serine 473 (Fig 6E) and migration in response to the chemokine CXCL10 (Fig 6F). 22 
Similarly, administration of the selective p110 inhibitor IC87114 during priming prevented 23 
biased differentiation of allogeneic CD4+ T cells towards an effector memory phenotype 24 
upon priming (Fig 6G-J). Of note, administration of IC87114 completely blocked Akt 25 
activation in HFD CD4+ T cells, but only partially in CD mice (Fig 5A, lanes 9-11 versus 3-5). 26 
Finally, to further causally link PI3K and Akt we also treated CD WT mice with the Akt-27 
13 
 
selective activator SC79. Similar to what we had observed in vitro (Fig 5K-L), this treatment 1 
led to increased effector memory differentiation to levels similar to those observed in HFD-2 
fed animals (Fig 6G-J and S6E). 3 
 4 
Inhibition of fatty acid oxidation prevents enhanced effector memory differentiation in 5 
saturated fatty acid-enriched diet. 6 
 7 
 Given the important role of fatty acid oxidation (FAO) in the generation of memory T 8 
cells (O'Sullivan et al., 2014), we assessed whether this metabolic pathway contributes to 9 
enhanced effector memory differentiation upon priming following saturated fatty acid-10 
enriched diet (PED). As shown in Fig 5E-H, enrichment of dietary palmitate led to enhanced 11 
differentiation of primed CD4+ T cells towards an effector memory phenotype. In vitro, naïve 12 
T cells increased their rate of oxidative phosphorylation (OCR: oxygen consumption rate) 13 
only in response to palmitic but not stearic acid (Fig 7A). Etomoxir is an irreversible inhibitor 14 
of carnitine palmitoyltransferase-1 (CPT-1), an upstream enzyme in the FAO cascade. We 15 
injected mice i.p. with etomoxir during priming in PED-fed mice and found that this treatment 16 
completely prevented biased differentiation of effector memory CD4+ T cells we observed 17 
upon priming following PED (Fig 7B-E).  18 
14 
 
DISCUSSION 1 
 2 
 Chronic systemic inflammation in obesity is characterised by the secretion of Th1 3 
cytokines as well as aberrant T cell infiltration of non-lymphoid tissue, including adipose 4 
tissue and arterial wall. Obese AT contains more Th1 lymphocytes and higher levels of IFN 5 
than its lean counterpart (Rocha et al., 2008). In this study we have tested the hypothesis 6 
that excess dietary saturated FA directly affects the differentiation and trafficking of CD4+ T 7 
cells to non-lymphoid tissues. We report that differentiation of memory CD4+ T cells primed 8 
in HFD-fed mice is biased towards a CD44hi-CCR7lo-CD62Llo-CXCR3+-LFA1+ effector 9 
memory-like phenotype without major changes in the size of the central memory pool. These 10 
T cells display preferential trafficking to non-lymphoid, inflammatory sites as well as 11 
increased effector function following adoptive transfer. Although metabolically imbalanced 12 
DC from obese/dyslipidaemic hosts tend to support Th1/Th17 responses (Chen et al., 2014; 13 
Eguchi et al., 2012; Reynolds et al., 2012; Shamshiev et al., 2007), our data show that they 14 
play no role in determining CD4+ T cell commitment to effector memory-like phenotype nor  15 
homing. The CD4+ T cell developmental bias is instead mediated by direct exposure of T 16 
cells to saturated FA, i.e. palmitate, leading to enhanced activation of a PI3K p110/Akt-17 
dependent pathway upon priming. Our data suggest that this pathway might involve 18 
mTORC2 leading to Akt activation but does not result in the downstream activation of 19 
mTORC1.  The key role of the PI3K p110/Akt axis is further confirmed by our observation 20 
that selective inactivation of p110 in HFD can re-establish homeostatic CD4+ T cell 21 
responses.  22 
A similar signalling cascade has previously been shown to direct the differentiation of 23 
CD8+ effector T cells (Finlay et al., 2012; Macintyre et al., 2011), whereby high levels of Akt 24 
activation led to the down-regulation of CD62L and CCR7 expression and redirected the 25 
trafficking of effector CD8+ T cells away from the secondary lymphoid tissues into the sites of 26 
inflammation.  Specifically, it has been shown that downstream of TCR engagement Akt 27 
15 
 
controls transcriptional programs directing cytotoxic T cell fate but is dispensable for T cell 1 
metabolism (Macintyre et al., 2011), whilst PDK1 directly regulates mTOR and hypoxia-2 
inducible factor 1 leading to an integrated control of metabolism and migration of CD8+ T 3 
cells (Finlay et al., 2012).  In addition to showing that similar signalling events underlay the 4 
differentiation of CD4+ T cells, our data expand the reach of these studies from the basic 5 
mechanisms of T cell activation and effector functions control to the biased establishment of 6 
unwanted T cell responses, i.e. specific pro-inflammatory effector and migratory phenotypes, 7 
in a pathophysiologic context such as obesity. This is in line with a recent study showing the 8 
link between obesity and metabolic diseases via increased Th17 T cell differentiation (Endo 9 
et al., 2015). It has also been reported that obesity could cause impairment in the T cell 10 
memory response to secondary influenza infection, thereby affecting vaccine efficacy 11 
(Karlsson et al., 2010). As we did not observe major differences in the size of the central 12 
memory population upon priming following HFD or CD, it is possible that central memory 13 
cells are functionally impaired in obesity. In line with the above study, we observed an 14 
altered DC function following HFD. 15 
 Interestingly, our data shown in Fig 5A suggest that in physiologic conditions (CD) 16 
different upstream kinases might control the activation of Akt induced upon T cell priming as 17 
the p110 inhibitor IC87114 did not completely block Akt phosphorylation. By contrast, in 18 
HFD mice Akt phosphorylation was completely abrogated by IC87114, indicating that the 19 
enhancement of Akt activation by dietary lipids is particularly dependent on p110. The 20 
molecular mechanisms of lipid exchange on the T cell membrane in physiology and during 21 
HFD remain to be fully established as well as the question as to whether FA act by altering 22 
the cell membrane lipid balance or by binding to specific receptors, as recently suggested  23 
(Eguchi et al., 2012; Haghikia et al., 2015; Wen et al., 2011). Our data showing increased 24 
membrane fluidity as well as enhanced formation of lipid rafts upon TCR engagement might 25 
provide some clues as to how excess dietary saturated FA impact on T cell responses. 26 
Similarly, our data suggest that specific mechanisms exist for palmitate sensing, which 27 
16 
 
remain to be defined. In this context, we have observed that T cell exposure to FA at the 1 
time of TCR triggering in vitro is not sufficient to induce the biased effector memory 2 
differentiation we observed in vivo, suggesting that palmitate sensing and alteration of the T 3 
cell membrane must occur prior to antigen recognition. Hence, the need to maintain naïve T 4 
cell viability over prolonged culture with or without FA and in the absence of antigen 5 
stimulation has been a major challenge in setting up in vitro models to study T cell 6 
differentiation following prolonged exposure to fat overload. We have partially overcome this 7 
issue by adding IL-7 to the culture of naïve T cells during incubation with or without FA prior 8 
to TCR stimulation, and this led to the results we showed in Fig 5I-J.  Defining in vitro 9 
systems of immunization following prolonged exposure to certain nutrients would be 10 
extremely useful to test pathways involved with T cell differentiation, such as palmitate 11 
sensing.  12 
 The observation that etomoxir prevents biased differentiation of effector memory 13 
CD4+ T cells upon priming following saturated fatty acid-enriched diet supports the concept 14 
that preferential utilization of FAO during T cell activation promotes effector memory CD4+ T 15 
cell differentiation following HFD. AMPK-induced FAO has been shown to play an important 16 
role in the generation of memory T cells (O'Sullivan et al., 2014). Increased FAO is also a 17 
feature of HFD (Cole et al., 2011; Schrauwen et al., 2000). However, reduced AMPK activity 18 
is also observed in HFD (Lindholm et al., 2013; Liu et al., 2006), and its reactivation by 19 
metformin is known to ameliorate glucose tolerance in obesity/type II diabetes. Thus, during 20 
HFD, AMPK-induced FAO is unlikely to play a role in the biased effector memory CD4+ T cell 21 
differentiation we observe. Whether and how an enhanced PI3K/Akt pathway leads to 22 
enhanced FAO remain open questions.   23 
 The biased development of pro-inflammatory effector memory CD4+ T cells occurred 24 
in mice within 4-8 weeks from exposure to HFD, a time that precedes overt obesity and 25 
associated complications. This might imply a causative role of altered T cell differentiation in 26 
the pathology accompanying metabolic stress and that immune challenges occurring 27 
17 
 
naturally in individuals before the establishment of overt obesity could drive cardiovascular 1 
disease later in life. 2 
 Finally, our observation that selective PI3K p110 and FAO inhibition can correct 3 
CD4+ biased differentiation might provide targets for the therapeutic control of inflammation 4 
during metabolic stress. Likewise, our study supports the notion that by modulating 5 
metabolism we can affect immune responses, a relatively novel concept with substantial 6 
translational implications. In this regard, hints and hopes come from few recent studies, such 7 
as the report that CD4+ T cells from systemic lupus erythematosus (SLE) patients exhibited 8 
enhanced glycolysis and mitochondrial metabolism that correlated with their activation status 9 
and their excessive IFNγ production was significantly reduced upon in vitro treatment with 10 
metformin. The same study also showed that in a number of murine lupus models the 11 
combination of metformin and 2-deoxy-glucose led to normalization of CD4+ T cell 12 
metabolism and overall reversed disease biomarkers (Mehta and Chandel, 2015; Yin et al., 13 
2015). Such studies pave the way to further research efforts in similar directions. 14 
  15 
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EXPERIMENTAL PROCEDURES 1 
 2 
Ethical statement 3 
 4 
 Human blood was obtained from healthy donors according to ethics approval 5 
obtained from the Università degli Studi di Milano (Cholesterol and Health: Education, 6 
Control and Knowledge – Studio CHECK [SEFAP/Pr.0003] – reference number Fa-04-Feb-7 
01). All in vivo experiments were conducted under the UK Home Office regulation (PPL 8 
70/7443). 9 
 10 
Study population 11 
 12 
 The Progressione della Lesione Intimale Carotidea (PLIC) Study (a sub-study of the 13 
CHECK Study) is a large survey of the general population living in the northern area of Milan 14 
(n=2,606; average age 66 years), (Baragetti et al., 2013; Norata et al., 2006; Norata et al., 15 
2007), followed at the Center for the Study of Atherosclerosis, Bassini Hospital (Cinisello 16 
Balsamo, Milan, Italy). An informed consent was obtained from subjects in accordance to the 17 
Declaration of Helsinki. For all participants, information on medical histories and therapies 18 
was obtained, and Body Mass Index (BMI, Kg/m2) and waist/hip ratio (W/H) were calculated. 19 
After an over-night fast, blood samples were collected from the antecubital vein for 20 
determination of lipid profile and glucose levels, as previously described (Ammirati et al., 21 
2012; Baragetti et al., 2013; Norata et al., 2007). Information on total leukocytes and sub-22 
fraction counts was available for n=1,172 subjects, representatives of the entire population in 23 
terms of age, gender distribution and clinical parameters according to the Kolmogorov-24 
Smirnov test. This cohort was divided by BMI in accordance to the World Health 25 
Organization definition (lean for BMI < 25 Kg/m2; overweight for 25 Kg/m2 ≤ BMI < 30 Kg/m2; 26 
obese for BMI  30 Kg/m2; www.who.int). 27 
 28 
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Polychromatic flow cytometry (human studies) 1 
 2 
 Polychromatic flow cytometry (10-parameter/8-color) was performed [as previously 3 
described (Ammirati et al., 2012)] to obtain a detailed characterization of a total of n=57 4 
subsets of circulating CD4+ T cells from n=187 subjects of the PLIC Study, representative of 5 
the entire population in terms of age, gender distribution and clinical parameters according to 6 
the Kolmogorov-Smirnov test. Whole blood from each subject was collected in EDTA 7 
anticoagulated tube (BD Vacutainer). Samples were stained and fixed on the day of 8 
collection. We previously verified that there was no significant difference in the investigated 9 
marker levels in samples stained immediately after collection in comparison to samples 10 
stained up to a maximum 24-hour time interval post-sampling and stored at room 11 
temperature. In order to reduce cellular loss and analysis sampling bias in the specimen, the 12 
no wash, whole blood lyses technique was used. Briefly, for each specimen, 50 μL of a 13 
mixture of 8 antibodies (CD3/CD4/CD45RO/CD45RA/CCR7/CCR5/CXCR3/HLA-DR) was 14 
added to 100 μL of whole blood followed by 20-minute incubation in the dark at room 15 
temperature.  In particular, the panel used consisted of the subsequent cellular surface 16 
markers: CD3 (Pacific Blue-labeled, clone HIT3a, BD Pharmingen), CD4 (APC-Cy7, SK3, 17 
BD Biosciences), CCR5/CD195 (PE, 2D7, BD Pharmingen), CXCR3/CD183 (FITC, 49801, 18 
R&D Systems Inc), CCR7/CD197 (PE-Cy7, 3D12, BD Pharmingen), HLA-DR (Quantum 19 
Red, HK14, Sigma-Aldrich), CD45RO (APC, UCHL1, Caltag), and CD45RA (ECD, 2H4, 20 
IOTest, Beckman Coulter). After staining, the red blood cells were lysed and fixed with the 21 
Immune-prep System (Beckman Coulter). White cells, diluted in 1 mL total volume were 22 
analyzed on a LSR II Flow Cytometer (BD Biosciences) equipped with four lasers and 23 
standard optics. The antibodies were selected to minimize spectral overlap. Furthermore, to 24 
reduce the non-specific fluorescence background and optimize the fluorescence signal, we 25 
used appropriately titrated directly conjugated monoclonal antibodies. To appropriately 26 
identify positively stained cells and differentiate them from background auto-fluorescence for 27 
gate inclusion, we used the Fluorescence Minus One strategy. Fluorescence intensity for 28 
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each signal measured was standardized using multiple peak Rainbow calibration particles 1 
(Code RCP-30-5A, Spherotech) to allow reproducible and comparable median fluorescence 2 
intensity throughout the study period, as previously described (Ammirati et al., 2010). We 3 
identified 7 principal T-cell subsets and 50 T-cell subpopulations derived by principal subsets 4 
by means of the combination of the surface markers. All data were acquired in FCS format 5 
using FACSDiva Software 5.0 (BD Biosciences). Lymphocytes were identified and 6 
electronically gated on forward and orthogonal light scatter signals. The fluorescent signals 7 
for phenotype analyses were accumulated for the gated lymphocytes. The raw data were 8 
stored electronically to a server for archiving and data processing. Data were processed and 9 
analyzed using FCS Express V3 Research edition (De Novo Software, 10 
Inc;http://www.denovosoftware.com). Cell viability was >99%, as assessed using the 11 
Molecular Probes Patented LIVE/DEAD Viability (Invitrogen), according to the manufacturer 12 
instructions. 13 
 14 
T cell activation 15 
 16 
 In vitro: murine CD4+ T cells were isolated with commercially available isolation kits 17 
(negative selection; Easysep, Invitrogen) according to manufacturer’s instructions from 18 
pooled lymph nodes (inguinal, mesenteric, axillary, brachial, superficial and deep cervical, 19 
lumbar and sacral) of C57Bl/6 mice and activated with plate bound anti-CD3 (1µg/ml, 20 
ebioscience) and anti-CD28 (5µg/ml, ebioscience), and IL-2 (10ng/ml, Roche) in the 21 
presence or absence of the Akt activator SC79 (500 nM, Tocris). In alternative isolated CD4+ 22 
T cells were cultured over night with IL-7 (1ng/ml, Peprotech) in the presence or absence of 23 
palmitic, linoleic or stearic acid (200µM, Sigma), followed by activation with plate bound anti-24 
CD3 (0.5µg/ml, ebioscience) and anti-CD28 (2.5µg/ml, ebioscience). 25 
 In vivo: in Rag2KO Marilyn C57Bl/6 female mice fed CD or HFD (Test Diet; Table S2) 26 
for 8 weeks memory antigen-specific (HY-specific) CD4+ T cells were generated by i.p. 27 
immunization with WT C57Bl/6 male splenocytes (1.5x106) for fourteen days. T cells were 28 
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then isolated from pooled lymph nodes of these mice (Fig 1A-D, 2A-G and S2A-F) and 1 
injected i.v. in recipients (see in vivo peritoneal recruitment below) or used for chemotaxis or 2 
flow cytometry.  3 
 In p110D910A or WT C57Bl/6 mice fed HFD (or CD as control), or PED (or PCD as 4 
control; Test Diet; Table S2) for 8 weeks, memory CD4+ T cells were generated by 5 
intraperitoneal immunization with CBA/BALBc splenocytes (1.5x106; allogeneic 6 
immunization) for seven days. T cells were then isolated from mesenteric lymph nodes of 7 
these mice and analysed by FACS or Western blot (Fig 2H; Fig 5A and E-H; Fig 6A-E and 8 
G-J; Fig 7). In this system, the PI3K p110δ inhibitor IC87114 (Tocris) was administered i.p. 9 
at a dose of 50 mg/kg daily during the 7-day immunization (Ying et al., 2012). The Akt 10 
activator SC79 (Tocris) was administered i.p. at a dose of 7 mg/kg daily during the 7-day 11 
immunization (Moreira et al., 2015). Etomoxir (Sigma) was administered i.p. at a dose of 15 12 
mg/kg daily during the 7-day immunization (Shriver and Manchester, 2011). 13 
 In OT-II p110D910A mice fed CD or HFD for 8 weeks, memory antigen-specific (OVA-14 
specific) CD4+ T cells were generated by intraperitoneal immunization with ovalbumin 15 
peptide (10µg, Cambridge Research Biochemicals) and Poly IC (1:1, Sigma) for seven days. 16 
T cells were then isolated from mesenteric lymph nodes of these mice (Fig 6F) and analyzed 17 
for chemotaxis. 18 
 19 
In vivo peritoneal recruitment  20 
 21 
 In vivo activated T cells from Rag2KO Marilyn female mice were isolated from pooled 22 
lymph nodes of HFD- or CD-fed donors, labelled with CFSE (HFD; 3.3µM, Invitrogen) or 23 
PKH26 (CD; 2µM, Sigma), pooled together and intravenously injected in HFD or CD 24 
recipient male mice (5x106 cells/mouse) that had received an intraperitoneal injection with 25 
zymosan (1mg/mouse, Sigma) and IFNγ (600 U/mouse, Peprotech) 48 hours earlier. 48 26 
hours after injection blood, peritoneal lavage, peritoneal membrane, mesenteric lymph nodes 27 
22 
 
and spleen were collected and analyzed by FACS for presence of CFSE- and PKH26-1 
labeled T cells. 2 
 3 
Membrane and intracellular FACS staining (murine studies)  4 
 5 
 Spleen and blood samples were lysed of their RBCs before staining. Dead cells were 6 
excluded from analysis by staining with fixable Aqua dead cell stain (Invitrogen). Isolated 7 
lymphocytes or DC were stained for surface markers; CD3, CD4, CD8, CD25, CD44, CCR7, 8 
CD62L, CXCR3, LFA1, Vβ6, CD40, CD80, CD86, MHCII, CD11c, CD19, CD14, F4/80  with 9 
fluorescently conjugated primary antibodies (1:200, ebioscience/BioLegend) at 4oC for 30 10 
minutes (37oC for CCR7) in FACS buffer (PBS + 2%FCS + 0.1% sodium azide) and fixed at 11 
4oC for 30 minutes with 1% PFA in FACS buffer. For intracellular staining isolated 12 
lymphocytes were incubated in permeabilization/fixation buffer (ebioscience) at 4oC for 1 13 
hour. Samples were washed in permeabilization buffer and stained for the 14 
cytokines/chemokine IFNγ, IL4 (1:200, ebioscience/BioLegend) and CXCL10 (1:200, 15 
Stratech) with fluorescently conjugated primary antibodies at 4oC for 30 minutes in 16 
permeabilization buffer. All samples were then assessed by flow cytometry using a LSR 17 
Fortessa (BD Biosciences) and FlowJo version 10 software. Dot plots were concatenated to 18 
be representative of the independent biological replicates used in each experiment. 19 
 20 
Chemotaxis 21 
 22 
 Chemotaxis assays were performed in 5 μm transwell inlays (Corning). In vivo 23 
primed lymphocytes were isolated from mice fed CD or HFD for 8 weeks, suspended in 24 
migration medium (RPMI 2% FCS) and seeded in the upper transwell chamber (3x105 25 
cells/transwell). Chemokines (PeproTech) were added to the lower chamber, CXCL10 (300 26 
ng/ml) or CCL19/21 (200 ng/ml of each chemokine). Migrated T cells were counted with a 27 
23 
 
haemocytometer 3, 6, and 24 hours after seeding, then percent of migrated cells were 1 
calculated.  2 
 3 
Western blot 4 
 5 
 Protein lysates were prepared from; i) mesenteric lymph nodes isolated from in vivo 6 
primed mice fed CD or HFD for 8 weeks, ii) CD4+ T lymphocytes isolated by magnetic beads 7 
(Mylteni) from lean subjects (median BMI 22.43 Kgm2, minimum 17.67 Kgm2-maximum 8 
24.54 Kgm2) and obese subjects (median BMI 31.64 Kgm2, minimum 30.48 Kgm2-9 
maximum 41.79 Kgm2) and iii) CD4+ T lymphocytes isolated from pooled lymph nodes and 10 
activated as described above for the indicated time points. Samples were lysed in Nonidet P-11 
40 lysis buffer (50 mM Hepes pH 8.0, 350 mM NaCl, 1% Nonidet P-40, 1 mM EDTA, 1 mM 12 
Na3VO4, 1 mM NaF, 20 mM glycerol-2-phosphate, 1 mM PMSF, 1 mM DTT, 10 μg/mL 13 
aprotinin, 10 μg/mL leupeptin, and a protease inhibitor mixture; Roche). Equivalent amounts 14 
of protein as determined by standard Bradford assay (Bio-Rad) were separated by 15 
SDS/PAGE and transferred to a Nylon membrane (GE Healthcare). Membranes were 16 
blocked for 2 hours at room temperature in 5% Milk/TBS-T (5% BSA/TBS-T for 17 
phosphorylation antibodies), incubated overnight at 4°C with primary antibodies (1:1000) 18 
and subsequently with HRP-conjugated secondary antibody (Amersham Bioscience) 19 
(1:5000). Antibodies against p-Akt (S473 and T308), Akt, p-S6 (S235/236), S6 and β-actin 20 
were purchased from Cell Signaling. Antibody against CCR7 was purchased from R&D. 21 
Density of bands was calculated relative to Akt, S6 or β-actin as shown in figures via the use 22 
of Image J software. 23 
 24 
RNA Isolation and Reverse Transcription 25 
 26 
24 
 
RNA was isolated using commercially available kits (Qiagen) according to the 1 
manufacturer’s instructions and assessed for quality and quantity using absorption 2 
measurements. Reverse transcription to cDNA was performed according to the 3 
manufacturer’s instruction (Applied Biosystems). 4 
 5 
qRT-PCR 6 
 7 
Gene expression analysis was done using SYBR Green Supermix (Biorad) in CFX connect 8 
light cycler (Biorad), according to the manufacturer’s instructions. Gene-relative expression 9 
was calculated using the ΔΔct method and normalized to a reference control (GAPDH): F 5’-10 
GGCTCATGACCACAGTCCA-3’; R 5’-CACATTGGGGGTAGGAACAC-3’. CCR7 and CD62L 11 
primers sequences were the same as published in Finlay DK et al. J Exp Med 2012. 12 
 13 
Mixed leukocyte reaction 14 
 15 
 In vitro: T cells were isolated from pooled lymph nodes of Rag2KO Marilyn female 16 
mice fed CD or HFD for 8 weeks and were labelled with CFSE (3.3µM) in PBS for 10 17 
minutes at room temperature.  T cells (2x105/well) were then stimulated with CD11c+ DC 18 
(7x104/well) isolated from the spleen of C57Bl/6 male mice fed CD or HFD for 8 weeks. 19 
CD11c+ DC were treated with mitomycin C to prevent proliferation prior to incubation with T 20 
cells. T cells were harvested 3 days later and CFSE dilution was assessed by flow cytometry 21 
(Fig 4A-B, S5A). 22 
 In vivo: T cells were isolated from pooled lymph nodes of Rag2KO Marilyn female 23 
mice, labelled with CFSE (3.3µM) in PBS for 10 minutes at room temperature and 24 
intravenously injected in C57Bl/6 recipient female mice (5x106 cells/mouse). Concurrently 25 
CD11c+ DC were isolated from the spleen of C57Bl/6 male mice fed CD or HFD for 8 weeks 26 
and intraperitoneally injected in the C57Bl/6 recipient female mice (¼ spleen derived 27 
25 
 
DC/mouse). Cells were harvested from the peritoneal lavage, spleen and draining lymph 1 
nodes 5 days later and CFSE dilution was assessed by flow cytometry (Fig S5B-C). 2 
 3 
Skin grafts 4 
 5 
 Rag2KO and Marilyn female mice fed CD or HFD for 8 weeks received a C57Bl/6 6 
male-derived skin graft on the upper right back. Bandages were removed 7 days post-7 
transplantation. Some Rag2KO mice were i.v. injected with 1x106 CD4+ T cells isolated from 8 
Marilyn females 9 days post-transplantation. Mice were observed for rejection for a further 3 9 
weeks. Mice were culled 4 weeks post-transplantation. 10 
 11 
Lipid raft staining 12 
 13 
 T cells isolated from pooled lymph nodes of C57Bl/6 mice fed CD or HFD for 8 weeks 14 
were activated as described above for 4 hours or left inactivated. Cells were stained with 15 
CTxB-FITC (8µg/ml, Sigma) and CD4-PECy7 (1:200, ebioscience) at 4oC for 30 minutes in 16 
FACS buffer (PBS + 2%FCS + 0.1% sodium azide) and fixed at 4oC for 30 minutes with 1% 17 
PFA in FACS buffer. Samples were assessed using Imagestream flow cytometer (Amnis) 18 
and IDEAS software. For quantitative image analysis of lipid raft aggregation, bright field and 19 
fluorescent cell images were acquired. Bright detail intensity of CTxB staining was used to 20 
quantify lipid raft aggregation. The bright detail intensity feature calculates the sum of 21 
intensity values from the brightest areas within a cell that are morphologically defined as the 22 
peak fluorescence distributions of 3 pixel radius or less. Five thousand CD4+ T cells were 23 
analysed per condition.  24 
 25 
Seahorse flux analysis 26 
 27 
26 
 
Oxidative metabolism was measured with a Seahorse XF96 Extracellular Flux Analyzer. As 1 
described before, isolated naïve CD4+ T cells were cultured over night with IL-7 in the 2 
presence or absence of palmitic or stearic acid. 2 x 105 CD4+ T cells were then seeded in a 3 
96-well microplate in XF Assay Modified DMEM and incubated in a non-CO2 incubator for 1 4 
hour prior to the assay. OCR was then measured according to the manufacturer’s 5 
instructions (Seahorse Bioscience). 6 
 7 
Statistical analysis 8 
 9 
 Statistical analysis of human data was performed using SPSS v.21.0 for Windows 10 
(IBM Corporation, Chicago Illinois, USA) program. Kolmogorov-Smirnov test was performed 11 
to test whether the studied cohort was representative of the entire PLIC population in terms 12 
of age, gender distribution and clinical parameters. Shapiro-Wilk test was performed to verify 13 
the normal distribution of linear variables; median and inter-quartile range (IQR) was 14 
reported and Mann-Whitney U non parametric test was performed. Outliers detection (above 15 
and below 1.5IQR) was performed by use of Grubb’s test. Spearman correlation 16 
coefficients () were reported for univariate correlations between linear variables. Analysis of 17 
Variances (ANOVA) test was performed to compare clinical parameters and leukocyte sub-18 
fraction among subjects divided by BMI and then adjusted for age, gender and therapies by 19 
using Analysis of Co-Variances (ANCOVA). For all analysis, statistically relevant differences 20 
were considered for p values < 0.05. 21 
 For murine studies, data are expressed as mean ± s.e.m. Two-tailed Student’s t-test 22 
was used to compare 2 groups with parametric data distribution. For multiple comparison 23 
analysis, 1-, 2- or 3-way ANOVA was used, unless otherwise specified (Fig 1E). In all case, 24 
a p-value of less than 5% was considered to be significant. 25 
  26 
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FIGURE LEGENDS 1 
 2 
Figure 1. Priming following HFD induces differentiation of a CD4+ T cell population 3 
that readily migrates to inflamed, non-lymphoid tissues independent of the metabolic 4 
status of the host. In vivo-primed CD4+ T cells isolated from pooled lymph nodes of HFD or 5 
CD Marilyn female donor mice, fluorescently labelled with CFSE or PKH26 respectively, in 6 
different tissue compartments (as described) of HFD or CD C57Bl/6 male recipient mice 48h 7 
post i.v. injection of donor cells. Male recipients were previously i.p. injected with zymosan 8 
(1mg/mouse) and IFNγ (600U/mouse). (A) Dot plots and quantification of donor cells in the 9 
blood circulation of CD recipient mice; 2hr, 24hr and 48hr post i.v. injection of donor cells. 10 
(B-D) Dot plots and quantification of the localisation of donor cells, fluorescently labelled with 11 
CFSE (HFD) or PKH26 (CD) in the peritoneal cavity (B), mesenteric lymph nodes (C) and 12 
spleen (D) of HFD or CD recipient mice. (E)  Survival curve of C57Bl/6 male skin grafts on 13 
HFD or CD Marilyn female recipient mice up to 28 days post-transplantation. (A-D) n=4-6 14 
independent recipients. (E) n=7 HFD, n=9 CD independent recipients. Values denote mean 15 
± s.e.m. *P<0.05; **P<0.01; ***P<0.001. (E) Mantel-Cox test, *P<0.05. 16 
 17 
Figure 2. HFD-induced metabolic stress promotes the differentiation of primed CD4+ T 18 
cells to a CXCR3+-LFA1+ effector memory-like phenotype in mice. (A-F) Cell surface 19 
staining of CD25, CD44, CCR7, CD62L, CXCR3 and LFA1 in in vivo-primed CD4+ T cells 20 
isolated from pooled lymph nodes of the HFD or CD Marilyn female donor mice used in Fig 21 
1A-D (absolute numbers). (G) Ex vivo chemotaxis (3hr, 6hr and 24hr time points) of in vivo-22 
primed CD4+ T cells isolated from pooled lymph nodes of the HFD or CD Marilyn female 23 
donor mice used in Fig 1A-D in response to CXCL10 (300ng/ml), CCL19/21 (200ng/ml of 24 
each chemokine) or media only. (H-I) Intracellular staining of IFN and IL4 in in vivo-primed 25 
CD4+ T cells isolated from mesenteric lymph nodes of HFD or CD mice. (A-F) n=4-6 26 
35 
 
independent donors. (G) n=3 independent donors (each donor was tested in duplicate). (H-I) 1 
n=5 independent mice. Values denote mean ± s.e.m. *P<0.05; **P<0.01; ***P<0.001. 2 
 3 
Figure 3. Obesity and body fat distribution in humans positively associates with an 4 
increase in CXCR3+ effector memory T cells. (A-D) Number of total lymphocytes (A) and 5 
% of helper, naïve and effector memory T cells (B-D) purified from the peripheral blood of 6 
lean, over-weight and obese subjects stratified according to BMI. (E) % of effector memory T 7 
cells purified from the peripheral blood of obese subjects stratified according to BMI either 8 
<35 or ≥35. (F-H) Correlation of naïve, effector memory and CXCR3+ T cells with 9 
android/gynoid ratio. (A) n=1,172. (B-D and F-H) n=187. (E) n=21 BMI <35, n=5 BMI≥35. 10 
ANCOVA, *P<0.05. 11 
 12 
Figure 4. Antigen presentation by DC from metabolically stressed donors does not 13 
affect T cell differentiation to a pro-inflammatory effector memory-like phenotype. (A) 14 
Dot plots and quantification of in vitro proliferation of CFSE-labelled CD4+ T cells isolated 15 
from pooled lymph nodes of HFD or CD Marilyn female mice incubated for 3 days with 16 
CD11c+ DC isolated from the spleen of HFD or CD C57Bl/6 male mice. Undivided and 4th 17 
division populations are quantified by dilution of the CFSE-label. (B) Cell surface staining of 18 
CD44, CCR7, CD62L and CXCR3 in the undivided population of CFSE-labelled CD4+ T cells 19 
shown in A. (C) Cell surface staining of CD40, CD80 and CD86 in CD11c+ DC used in A. (A-20 
B) n=3 independent mice (each mouse was tested in triplicate). (C) n=3 independent mice. 21 
Values denote mean ± s.e.m. **P<0.01; ***P<0.001. 22 
 23 
Figure 5. Direct exposure of CD4+ T cells to saturated FA causes enhanced activation 24 
of a PI3K p110/Akt-dependent pathway upon priming. (A) Levels and densitometric 25 
quantification of p-Akt (S473), Akt, p-S6 (S235/236) and -actin protein expression in in vivo-26 
primed CD4+ T cells isolated from mesenteric lymph nodes of CD and HFD mice i.p. injected 27 
36 
 
with the PI3K inhibitor IC87114 or left untreated. (B) Levels and densitometric quantification 1 
of p-Akt (S473) and Akt protein expression in CD4+ T cells purified from the peripheral blood 2 
of lean and obese human subjects. (C) Membrane fluidity index in in vivo-primed CD4+ T 3 
cells isolated from mesenteric lymph nodes of CD and HFD mice, calculated as the ratio of 4 
oleic acid (C18:1) to linoleic acid (C18:2). (D) Cell surface staining of CTxB in in vitro 5 
activated (Act) CD4+ T cells isolated from the lymph nodes of CD and HFD mice. 6 
Quantification of aggregation of CTxB is measured by Bright Detail Intensity of the signal. (E-7 
H) Cell surface staining of CD44, CCR7, CD62L, CXCR3 and LFA1 in in vivo-primed CD4+ T 8 
cells isolated from mesenteric lymph nodes of PED and PCD mice. (I-J) Protein levels and 9 
densitometric quantification of p-Akt (S473), Akt, p-S6 (S235/236) and S6 protein expression 10 
(I), and gene expression of  CCR7 and CD62L (J) in CD4+ T cells isolated from pooled 11 
lymph nodes of mice and cultured over night with IL-7 (1ng/ml) in the presence or absence 12 
of palmitic, linoleic or stearic acid (200µM), followed by activation with plate bound anti-CD3 13 
(0.5µg/ml) and anti-CD28 (2.5µg/ml) for the indicated time points. (K-L) Levels of CCR7 and 14 
CD62L gene expression (K) and CCR7 protein (L) in CD4+ T cells isolated from pooled 15 
lymph nodes of mice, then activated with plate bound anti-CD3 (0.5µg/ml) and anti-CD28 16 
(2.5µg/ml) for the indicated time points in the presence or absence of the Akt activator SC79 17 
(500 nM). (A-B) Each lane shows data from independent mouse/human samples. (C-H) 18 
n=3-6 independent mice. (I) Representative data of n=3 independent mice. (J-L) 3-6 pooled 19 
mice. Values denote mean ± s.e.m. *P<0.05; **P<0.01; *** P<0.001. 20 
 21 
Figure 6. The PI3K/Akt pathway is key for the differentiation of CXCR3+ effector 22 
memory T cells.  (A-D) Cell surface staining of CD44, CCR7, CD62L, CXCR3 and LFA1 in 23 
in vivo-primed CD4+ T cells isolated from mesenteric lymph nodes of HFD P110D910A or WT 24 
C57Bl/6 mice. (E) Levels and densitometric quantification of p-Akt (S473), Akt, p-S6 25 
(S235/236) and S6 protein expression in in vivo-primed CD4+ T cells from A-D. (F) Ex vivo 26 
chemotaxis (3hr, 6hr and 24hr time points) of in vivo-primed CD4+ T cells isolated from 27 
37 
 
mesenteric lymph nodes of HFD or CD OT-II P110D910A mice in response to CXCL10 1 
(300ng/ml), CCL19/21 (200ng/ml of each chemokine) or media only. (G-J) Cell surface 2 
staining of CD44, CCR7, CD62L, CXCR3 and LFA1 in in vivo-primed CD4+ T cells isolated 3 
from mesenteric lymph nodes of CD and HFD mice i.p. injected with the PI3K inhibitor 4 
IC87114, the Akt activator SC79 or left untreated. (A-E, G-J) n=5 independent mice. (F) n=4 5 
independent mice (each mouse was tested in duplicate). Values denote mean ± s.e.m. 6 
*P<0.05; **P<0.01; *** P<0.001. 7 
 8 
Figure 7.  Inhibition of FAO prevents enhanced effector memory differentiation in 9 
saturated fatty acid-enriched diet. (A) OCR of naïve CD4+ T cells isolated from pooled 10 
lymph nodes of mice and cultured over night with IL-7 (1ng/ml) in the presence or absence 11 
of palmitic or stearic acid (200µM). (B-E) Cell surface staining of CD44, CCR7, CD62L, 12 
CXCR3 and LFA1 in in vivo-primed CD4+ T cells isolated from mesenteric lymph nodes of 13 
PED or PCD mice i.p. injected with etomoxir or left untreated. (A) 6 pooled mice tested in 6-14 
10 replicates per treatment. (B-E) n=5 independent mice. Values denote mean ± s.e.m. 15 
*P<0.05; **P<0.01. 16 
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Triglycerides (mg/dL) 77 (50-139.4) 96 (56-163) 99 (64-182) < 0.001  
LDL-C (Friedewald 
Formula) 
119.2 (81.56-
158.8) 
118.20 (80.92-
167.48) 
118.80 (77.26-
158.72) 
0.714 
ApoA-I (mg/dL) 165 (125.8-179) 154 (115.7-175) 151 (115-174) < 0.001  
Apo-B (mg/dL) 99 (83-131) 101 (79.6-134) 99 (81-128) 0.712 
Fasting glucose levels 
(mg/dL) 
88 (75-104) 93 (80-114) 100 (84-133) < 0.001 
Total leukocytes (x103 
U/L) 
5.71 (4.33-8.20) 6.36 (4.74-8.80) 6.39 (4.71-8.82) < 0.001  
Neutrophils (x103 U/L) 3.31 (2.12-5.12) 3.56 (2.43-5.39) 3.59 (2.38-5.33) 0.010  
Lymphocytes (x103 
U/L) 
1.78 (1.13-2.55) 1.92 (1.36-2.73) 1.95 (1.32-2.77) < 0.001  
Monocytes (x103 U/L) 0.49 (0.34-0.75) 0.56 (0.39-0.80) 0.55 (0.38-0.81) 0.002  
Eosinophils (x103 U/L) 0.12 (0.05-0.27) 0.15 (0.07-0.33) 0.16 (0.07-0.33) 0.062 
Basophils (x103 U/L) 0.03 (0.01-0.05) 0.03 (0.01-0.05) 0.03 (0.05) 0.668 
Table S1 
High Fat diet 
(HFD) 
Chow diet (CD) Palmitate-
enriched diet 
(PED) 
Palmitate-
control diet  
(PCD) 
Fat (%) 34.9 9.1 25.2 4.2 
Cholesterol, ppm 
Linoleic Acid (%) 
Linolenic Acid (%) 
Arachidonic Acid (%) 
Omega-3 Fatty Acids (%) 
Total Saturated (%)  
Total Mono-saturated (%) 
Polyunsaturated (%) 
301 
4.7 
0.39 
0.06 
0.39 
13.68 
14 
- 
200 
2.32 
0.21 
0.02 
0.32 
2.72 
2.88 
- 
0 
3.86 
0.29 
0 
0.29 
10.05 
10.38 
4.38 
0 
1.89 
0.29 
0 
0.21 
0.39 
1.56 
2.07 
Energy (kcal/g)2 5.1 3.56 4.83 3.78 
Protein (%) 
Fat (%) 
Carbohydrate (%) 
18.1 
61.6 
20.3 
23 
22 
55 
13 
47 
40 
16.7 
10 
73.3 
Table S2 
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Supplemental Figures  and Tables Legends 1 
 2 
Supplemental Figure 1 (related to Fig 1). In vivo peritoneal recruitment and Rag2KO 3 
skin grafts. (A-B) Schematic of the design (A) and timeline (B) of the in vivo peritoneal 4 
recruitment model used in Fig 1A-D. (C) Weight gain curves of mice over the 8 weeks HFD 5 
or CD in C57Bl/6 male recipients and Marilyn female donors. (D) Survival curve of C57Bl/6 6 
male skin grafts on HFD or CD Rag2KO female recipients up to 21 days post-7 
transplantation. Also shown is the survival curve following reconstitution of HFD Rag2KO 8 
mice with CD4+ T cells isolated from Marilyn female mice. (C-D) n=3-6 independent mice. 9 
(C) Values denote mean ± s.e.m. *P<0.05; **P<0.01. 10 
 11 
Supplemental Figure 2 (related to Fig 2). HFD-induced differentiation of CXCR3+-LFA1+ 12 
effector memory-like phenotype in mice and in vivo sources of CXCL10. (A-F) Cell 13 
surface staining of CD25, CD44, CCR7, CD62L, CXCR3 and LFA1 in in vivo-primed CD4+ T 14 
cells isolated from pooled lymph nodes of the HFD or CD Marilyn female donor mice used in 15 
Fig 1A-D (%). (G) Gating strategy defining immune cells tested for expression of CXCL10 in 16 
the peritoneal cavity 48 hours after i.p. injection of IFNγ (600U/mouse). (H) MFI of CXCL10 17 
in the immune cell types defined in G. (A-F) n=4-6 independent donors. (H) n=2 independent 18 
mice. (A-F) Values denote mean ± s.e.m. *P<0.05; **P<0.01; *** P<0.001. 19 
 20 
Supplemental Figure 3 (related to Fig 3). Flow cytometry gating strategy to identify 21 
CD4+ T cell subsets in humans. Examples of the gating strategy used in an obese (A) and 22 
a lean (B) individual to identify the principal CD4+ T cell subsets and some of the T cell 23 
subpopulations in the peripheral blood samples of lean, over-weight and obese subjects. 24 
 25 
Supplemental Figure 4 (related to Fig 3). Body fat distribution association with 26 
inflammatory T cell subsets and inflammatory mediators. (A-B) Levels of CRP in the 27 
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blood of lean, over-weight and obese subjects stratified according to BMI (A) and correlation 1 
of CRP with effector memory T cells (B). (C) Body mass fat distribution of android and 2 
gynoid fat within a lean, overweight and obese individual (analysed with body composition by 3 
dual-energy X-ray absorptiometry, DEXA). (D-E) Correlation of HLADR+ (D) and CCR5+ 4 
effector memory T cells (E) with android/gynoid ratio. (A-B, D-E) n=187. ANCOVA, *P<0.05. 5 
 6 
Supplemental Figure 5 (related to Fig 4). Dendritic cells from HFD-fed mice do not 7 
affect T cell differentiation. (A) Dot plots and quantification of in vitro proliferation of CFSE-8 
labelled CD4+ T cells isolated from pooled lymph nodes of CD Marilyn female mice 9 
incubated with CD11c+ DC isolated from the spleen of HFD or CD C57Bl/6 male mice for 3 10 
days. Undivided and 4th division populations are quantified by dilution of the CFSE-label. (B) 11 
Dot plots and quantification of in vivo proliferation of CFSE-labelled CD4+ T cells isolated 12 
from pooled lymph nodes of CD Marilyn female i.v. injected into C57Bl/6 female recipient 13 
mice in combination with CD11c+ dendritic cells isolated from the spleen of HFD or CD 14 
C57Bl/6 male mice i.p. injected for 5 days. Undivided, 1st and 2nd division populations are 15 
quantified from the spleen and mesenteric lymph nodes of recipient females by dilution of 16 
the CFSE-label. (C) Cell surface staining of CD44 and CCR7 in the population of CFSE-17 
labelled CD4+ T cells isolated in vivo from the spleen and mesenteric lymph nodes of the 18 
C57Bl/6 recipient female mice. (A) n=3 independent mice (each mouse was tested in 19 
triplicate). (B-C) n=4 independent mice. Values denote mean ± s.e.m. *P<0.05; ** P<0.01; 20 
***P<0.001. 21 
 22 
Supplemental Figure 6 (related to Fig 5 and 6). Mechanistic insights in to saturated 23 
FA-induced effector memory differentiation of CD4+ T cells. (A) Levels and 24 
densitometric quantification of p-Akt (T308), Akt, p-S6 (S235/236) and S6 protein expression 25 
in in vivo-primed CD4+ T cells isolated from mesenteric lymph nodes of CD and HFD mice 26 
i.p. injected with the PI3K inhibitor IC87114 or left untreated. (B) Volcano plot of fatty acids 27 
and phospholipids detected in in in vivo-primed CD4+ T cells isolated from mesenteric lymph 28 
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nodes of CD and HFD mice. Fifteen fatty acids were detected including palmitic acid C16:0; 1 
palmitoleic acid C16:1; margaric acid C17:0; stearic acid C18:0; oleic acid C18:1; linoleic 2 
acid C18:2; γ-linolenic acid C18:3; arachic acid C20:0; arachidonic acid C20:4; 3 
eicosapentaenoic acid C20:5 (EPA); behenic acid C22:0; erucic acid C22:1; 4 
docosahexaenoic acid C22:6 (DHA); lignoceric acid C24:0; nervonic acid C24:1. Out of 356 5 
phospholipids analyzed (including LysoPC: lysophosphatidylcholine; PC: 6 
phosphatidylcholine; PC aa: phosphatidylcholine acyl-acyl; PC ae: phosphatidylcholine acyl-7 
alkyl also known as plasmalogens; PE: phosphatidylethanolamine; PE aa: 8 
phosphatidylethanolamine acyl-acyl; PE ae: phosphatidylethanolamine acyl-alkyl also known 9 
as plasmalogens; PS: phosphatidylserines; LysoPI: lysophosphatidylinositol; PI: 10 
phosphatidylinositol; PG: phosphatidylglycerol; LysoPA: lysophosphatidic acid; PA: 11 
phosphatidic acid; SM: sphingomyelin; Cer: ceramide; GCer: glucosyl/galactosyl-ceramide; 12 
LacCer: lactosyl-ceramide and gangliosides GM1, GM2 and GM3) 229 different species 13 
belonging to different families were detected. The volcano plot displays the relationship 14 
between fold-change (expressed as log2) and significance between the two groups (CD vs. 15 
HFD), using a scatter plot view. The y-axis is the negative log10 of p values (a higher value 16 
indicates greater significance as indicated by dashed lines) and the x-axis is the difference in 17 
levels of metabolites between two experimental groups. Significantly increased metabolites 18 
are shown by blue dots while red dots represented those decreased. (C) Representative 19 
fluorescence images of the aggregation of CTxB signal. (D) Levels and densitometric 20 
quantification of p-Akt (S473) and Akt protein expression in CD4+ T cells isolated from 21 
pooled lymph nodes of mice, then activated with plate bound anti-CD3 (0.5µg/ml, 22 
ebioscience) and anti-CD28 (2.5µg/ml, ebioscience) for 6hrs in the presence or absence of 23 
the Akt activator SC79 (500 nM). (E) Levels and densitometric quantification of p-Akt (T308) 24 
and Akt protein expression in in vivo-primed CD4+ T cells isolated from mesenteric lymph 25 
nodes of CD mice i.p. injected with the Akt activator SC79 or left untreated. (A, D-E) Each 26 
lane shows data from independent mouse samples. (B) n=3 independent mice. Values 27 
denote mean ± s.e.m. *P<0.05; **P<0.01. 28 
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 1 
Supplemental Table 1 (related to Fig 3). Parameters analysed in the n=1,172 subjects 2 
selected. All the variables were non-normally distributed (Kolmogorov-Smirnov test). Median 3 
(Interquartile-Range, IQR) are presented for each variable across subjects divided into lean 4 
(BMI< 25 Kg/m2), overweight (BMI≥ 25 Kg/m2) and obese (BMI < 30 Kg/m2). Grubb’s test 5 
was performed for detection of outliers (below and above 1.5∗IQR) for each distribution. P is 6 
derived from Analysis of covariance (ANCOVA) adjusting for age, gender and therapies. 7 
 8 
Supplemental Table 2 (related to Fig 1, 2 and 4-7). Nutrients and caloric composition 9 
of diets: HFD, CD, PED and PCD. 10 
 11 
Supplemental Experimental Procedures 12 
 13 
Determination of abdominal adiposity (android/gynoid ratio) 14 
 15 
 Total body DXA scans were acquired using Lunar iDXA (GE Healthcare, Madison, 16 
WI). Daily quality control scans were acquired during the study period. All subjects were 17 
scanned while wearing a hospital gown with all metal artifacts removed from their body. 18 
Trained operators, blinded on patient’s identity and clinical history, performed all scans. 19 
Patient positioning and data acquisition was conducted in accordance to the operator’s 20 
manual. Lunar iDXA scans were analyzed with the enCORE software (version 14.0), (GE 21 
Healthcare, Madison, WI), (Rothney et al., 2013). Out of total weight, the software allows to 22 
discriminate the bone mass, the fat mass and the lean mass. DXA android fat was computed 23 
automatically over the DXA android region, a region-of-interest automatically defined by the 24 
enCORE software, whose caudal limit is automatically placed at the top of the iliac crest and 25 
whose height is set to 20% of the distance from the top of the iliac crest to the base of the 26 
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skull to define its cephalad limit. DEXA gynoid fat was computed automatically as well, over 1 
the DXA gynoid region (percent of fat tissue in inferior half abdominal, glutei and femoral 2 
regions); their ratio is automatically determined by the software to give the gender-adjusted 3 
measure of abdominal obesity (Rothney et al., 2013). 4 
 5 
Lipidomic profile by liquid chromatography-tandem mass spectrometry (LC-MS/MS) 6 
 7 
 All HPLC solvents were MS grade (Carlo Erba); fatty acid internal standards 13C-8 
labelled palmitic acid (C16:0) and 13C-labelled linoleic acid (C18:2) were purchased from 9 
Sigma. Phospholipid standards: C13:0 lysophosphatidylcholines (LPC); C:25:0 10 
phosphatidylcholines (PC); C12:0 sphingomyelin (SM); 12:0-13:0 phosphatidylserine (PS); 11 
12:0-13:0 phosphatidylinositol (PI); 12:0-13:0 phosphatidylglycerol (PG); 12:0-13:0 12 
phosphatidic acid (PA); 12:0-13:0 phosphatidylethanolamine (PE); C12 ceramide (Cer); 13 
glucosyl (β) C12 ceramide (GC); lactosyl (β) C12 ceramide (LacCer); C17 mono-sulfo 14 
galactosyl-(β)-ceramide (D18:1/17:0; GalCer); were purchased from Avanti Polar Lipids. 15 
Quantification of fifteen different fatty acids was performed as previously described 16 
(Cermenati et al., 2015). Briefly, samples were homogenized in methanol:acetonitrile (1:1). 17 
Aliquots of extracts, after addition of internal standards (13C-labelled palmitic and linoleic 18 
acids), were subjected to acid hydrolysis and processed as previously described (Cermenati 19 
et al., 2015). Fatty acid quantification was performed on a API-4000 triple quadrupole mass 20 
spectrometer (AB Sciex) coupled with a HPLC system (Agilent) and CTC PAL HTS auto-21 
sampler (PAL System) using standard curves for each fatty acid analyzed. For the 22 
quantification of the different phospholipids, the MS analysis was performed with a flow 23 
injection analysis-tandem mass spectrometry (FIA-MS/MS) method. The identity and 24 
quantification of the different phospholipids were confirmed using pure standards. 25 
Methanolic:acetonitrile extracts were analyzed by a 5 min run in both positive and negative 26 
ion mode with a 268 multiple reaction monitoring (MRM) transition in positive mode and 88 27 
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MRM transition in negative mode. An ESI source connected with an API 4000 triple 1 
quadrupole instrument (AB Sciex) was used.  The mobile phase was 0.1 % formic acid in 2 
MeOH for FIA positive analysis and 5 mM ammonium acetate pH 7 in MeOH for FIA 3 
negative. MultiQuant™ software version 3.0.2 was used for data analysis and peak review of 4 
chromatograms. Each metabolite level detected was normalized on protein content. 5 
